Cytokeratin 19
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Cytokeratin 19, abbreviated CK19, is a commonly available (low molecular weight) keratin immunostain.[1]
Positive
Benign
Tumour/malignant
- Adamantinoma.
- Cholangiocarcinoma.
- Yolk sac tumour.[3]
- Breast carcinoma - common (~91%).[4]
- Lung adenocarcinoma (~95%).[4]
Negative
See also
References
- ↑ Yui, T.; Ohmachi, T.; Matsuda, K.; Okamoto, M.; Taniyama, H. (Apr 2015). "Histochemical and immunohistochemical characterization of chordoma in ferrets.". J Vet Med Sci 77 (4): 467-73. doi:10.1292/jvms.14-0488. PMID 25648567.
- ↑ 2.0 2.1 2.2 Jain, R.; Fischer, S.; Serra, S.; Chetty, R. (Jan 2010). "The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.". Appl Immunohistochem Mol Morphol 18 (1): 9-15. doi:10.1097/PAI.0b013e3181ad36ea. PMID 19956064.
- ↑ Bremmer, F.; Ströbel, P.; Hubertus, H.; Strecker, J.; Gaisa, N.; Strauß, A.; Schweyer, S.; Radzun, H-J. et al. (2015). [www.diagnosticpathology.org/content/10/1/7Cached "CK19 is a sensitive marker for yolk sac tumours of the testis."]. Diagnostic Pathology 10 (7). doi:10.1186/s13000-015-0243-y. www.diagnosticpathology.org/content/10/1/7Cached.
- ↑ 4.0 4.1 Masai, K.; Nakagawa, K.; Yoshida, A.; Sakurai, H.; Watanabe, S.; Asamura, H.; Tsuta, K. (Dec 2014). "Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases.". Lung Cancer 86 (3): 318-23. doi:10.1016/j.lungcan.2014.09.018. PMID 25453845.